Announcements Trials
Browse Landscape

Phase

Phase 2 15Phase 1/2 4Phase 1 3Phase NA 1Phase EARLY_PHASE1 1Phase 3 1Phase 2/3 1

Status

Completed 5Not yet recruiting 3Unknown 1Terminated 1Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Myeloid 1Lymphoid 1

Conditions

Myelodysplastic Syndromes 1Lymphoma, Non-Hodgkin 1

Interventions

Radiosurgery 28Magnetic Resonance Spectroscopy 25Blood Specimen Collection 20Radiotherapy 19Surveys and Questionnaires 18Exercise 16Early Intervention, Educational 16Methods 15Cyclophosphamide 15Surgical Procedures, Operative 14Standard of Care 14Radiotherapy, Intensity-Modulated 14Biopsy 13Acupuncture Therapy 12Interviews as Topic 11Cisplatin 11Filgrastim 10Educational Status 10Radiofrequency Ablation 9Magnetic Resonance Imaging 9Fluorodeoxyglucose F18 9fludarabine phosphate 8Radiation 8Gemcitabine 8X-Rays 7Sorafenib 7Practice Guidelines as Topic 7Granulocyte Colony-Stimulating Factor 7Colonoscopy 7Capecitabine 7

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase NA × Terminated × Thiotepa × Clear all
NCT01598025 2018-08-09

Biparental HLA Haplotype Disparate T-cell Depleted Transplants for Patients Lacking an HLACompatible Donor

Memorial Sloan Kettering Cancer Center

Phase NA Terminated
3 enrolled 7 charts
LymphoidMyeloid

Lymphoma, Non-Hodgkin, Myelodysplastic Syndromes

Data powered by HemOnc (CC BY 4.0) Colophon âš¡